Pitavastatin-Reference-Cited by-同舟云学术

Pitavastatin

Published:2010-09 Issue:5 Volume:18 Page:264-267
ISSN:1061-5377
Container-title:Cardiology in Review
language:en
Short-container-title:

Author:

Ahmad Haniyyah,Cheng-Lai Angela

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference18 articles.

1. Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque: comparison with atorvastatin.;Toi;Circ J,2009

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).;Lancet,1994

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.;Sacks;N Engl J Med,1996

4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.;N Engl J Med,1998

5. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomized placebo-controlled trial.;Lancet,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Applications of Quinolinium Salts in the Synthesis of Annulated Heterocycles;SynOpen;2022-04-25

2. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge;World Journal of Gastroenterology;2020-07-28

3. Pitavastatin ameliorates myocardial damage by preventing inflammation and collagen deposition via reduced free radical generation in isoproterenol-induced cardiomyopathy;Clinical and Experimental Hypertension;2018-09-07

4. Open-label randomized non-inferiority trial of a fixed-dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin;Diabetic Medicine;2015-12-12

5. Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial;Clinical Therapeutics;2014-08